Comparative effects of pranidipine with amlodipine in rats with heart failure

Punniyakoti T. Veeraveedu, Kenichi Watanabe, Meilei Ma, Narasimman Gurusamy, Suresh S. Palaniyandi, Juan Wen, Paras Prakash, Mir Imam Ibne Wahed, Fadia Kamal, Sayaka Mito, Megumi Kunisaki, Makoto Kodama, Yoshifusa Aizawa

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The aim of the present study was to compare the cardioprotective properties of long-acting calcium channel antagonist pranidipine with amlodipine in rat model of heart failure induced by autoimmune myocarditis. Twenty-eight days after immunization the surviving rats were randomized for the oral administration of low-dose amlodipine (1 mg/kg/day), high-dose amlodipine (5 mg/kg/ day), pranidipine (0.3 mg/kg/day) or vehicle (0.5% methylcellulose). After oral administration for 1 month, the animals underwent echocardiography and hemodynamic analysis. Histopathology, immunohistochemistry, and Western immunoblotting were carried out in the heart samples. Both pranidipine and high-dose amlodipine increased survival rate. Although the heart rate did not differ among the four groups, left ventricular end-diastolic pressure was significantly decreased and ± dP/dt was increased in the pranidipine- and high-dose amlodipine-treated rats, but not in low-dose amlodipine-treated rats. In comparison to amlodipine treatment, pranidipine treatment significantly reduced myocyte size and central venous pressure. Furthermore, both pranidipine and high-dose amlodipine treatment significantly reduced myocardial protein levels of atrial natriuretic peptide and inducible nitric oxide synthase, whereas pranidipine only significantly decreased tumor necrosis factor-α, and improved sarcoplasmic reticulum Ca2+ATPase2 protein levels. We conclude that pranidipine ameliorates the progression of left ventricular dysfunction and cardiac remodeling in rats with heart failure after autoimmune myocarditis in a lower dose when compared to amlodipine and which may be a clinically potential therapeutic agent for the treatment of heart failure.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
Issue number1
StatePublished - May 2006

All Science Journal Classification (ASJC) codes

  • Pharmacology


Dive into the research topics of 'Comparative effects of pranidipine with amlodipine in rats with heart failure'. Together they form a unique fingerprint.

Cite this